Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1780

1.

Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.

Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1418-23.

PMID:
15050318
2.

Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer.

Goguen LA, Posner MR, Tishler RB, Wirth LJ, Norris CM, Annino DJ, Sullivan CA, Li Y, Haddad RI.

Arch Otolaryngol Head Neck Surg. 2006 May;132(5):526-31.

PMID:
16702569
3.
4.

Preoperative chemotherapy-sensitized radiation therapy for cervical metastases in head and neck cancer.

Puc MM, Chrzanowski FA Jr, Tran HS, Liu L, Glicksman AS, Landman C, Slotman GJ.

Arch Otolaryngol Head Neck Surg. 2000 Mar;126(3):337-42.

PMID:
10722006
5.

Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer?

McHam SA, Adelstein DJ, Rybicki LA, Lavertu P, Esclamado RM, Wood BG, Strome M, Carroll MA.

Head Neck. 2003 Oct;25(10):791-8.

PMID:
12966502
6.

Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.

Lavertu P, Adelstein DJ, Saxton JP, Secic M, Wanamaker JR, Eliachar I, Wood BG, Strome M.

Head Neck. 1997 Oct;19(7):559-66.

PMID:
9323143
7.

Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.

Rengan R, Pfister DG, Lee NY, Kraus DH, Shah JP, Shaha AR, Ben-Porat LS, Zelefsky MJ.

Am J Clin Oncol. 2008 Oct;31(5):465-9. doi: 10.1097/COC.0b013e31816a6208.

PMID:
18838883
8.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
9.

Toxic cure: Hyperfractionated radiotherapy with concurrent cisplatin and fluorouracil for Stage III and IVA head-and-neck cancer in the community.

Maguire PD, Meyerson MB, Neal CR, Hamann MS, Bost AL, Anagnost JW, Ungaro PC, Pollock HD, McMurray JE, Wilson EP, Kotwall CA.

Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):698-704.

PMID:
14967423
10.

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.

Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.

Head Neck. 2004 May;26(5):447-55.

PMID:
15122662
11.

Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.

Lau H, Phan T, Mackinnon J, Matthews TW.

Arch Otolaryngol Head Neck Surg. 2008 Mar;134(3):257-61. doi: 10.1001/archoto.2007.49.

PMID:
18347249
12.

Early nodal response as a predictor for necessity of functional neck dissection after chemoradiation.

Vongtama R, Lee M, Kim B, Sercarz J, Lin K, Suchard MA, Lee SP, Juillard G.

Cancer J. 2004 Nov-Dec;10(6):339-42.

PMID:
15701264
13.

Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.

Hanna E, Alexiou M, Morgan J, Badley J, Maddox AM, Penagaricano J, Fan CY, Breau R, Suen J.

Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):861-7.

PMID:
15262764
14.

Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.

Frank DK, Hu KS, Culliney BE, Persky MS, Nussbaum M, Schantz SP, Malamud SC, Holliday RA, Khorsandi AS, Sessions RB, Harrison LB.

Laryngoscope. 2005 Jun;115(6):1015-20.

PMID:
15933512
15.

Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution.

Adelstein DJ, Saxton JP, Rybicki LA, Esclamado RM, Wood BG, Strome M, Lavertu P, Lorenz RR, Carroll MA.

J Clin Oncol. 2006 Mar 1;24(7):1064-71.

PMID:
16505425
16.

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40.

PMID:
17515501
17.

Surgical resection is necessary to maximize tumor control in function-preserving, aggressive chemoradiation protocols for advanced squamous cancer of the head and neck (stage III and IV).

Wanebo H, Chougule P, Ready N, Safran H, Ackerley W, Koness RJ, McRae R, Nigri P, Leone L, Radie-Keane K, Reiss P, Kennedy T.

Ann Surg Oncol. 2001 Sep;8(8):644-50.

PMID:
11569779
18.

A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy.

Soltys SG, Choi CY, Fee WE, Pinto HA, Le QT.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):994-9. doi: 10.1016/j.ijrobp.2011.07.042. Epub 2011 Dec 2.

PMID:
22137026
19.

Planned post-chemoradiation neck dissection: significance of radiation dose.

Stenson KM, Huo D, Blair E, Cohen EE, Argiris A, Haraf DJ, Vokes EE.

Laryngoscope. 2006 Jan;116(1):33-6.

PMID:
16481805
20.

The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary.

Medini E, Medini AM, Lee CK, Gapany M, Levitt SH.

Am J Clin Oncol. 1998 Apr;21(2):121-5.

PMID:
9537194

Supplemental Content

Support Center